AI assistant
Sending…
RYVU Therapeutics S.A. — Director's Dealing 2023
Feb 3, 2023
5798_rns_2023-02-03_15f638b6-0f9f-4e38-8a1a-d8bfbff1d548.html
Director's Dealing
Open in viewerOpens in your device viewer
Notification from a person discharging managerial responsibilities inthe Company - Article 19 of MAR
The Management Board of Ryvu Therapeutics S.A. (_quot;Company_quot;) herebyinforms that the Company received a notification prepared on the basisof Article 19(1) of the Market Abuse Regulation from Mr. PiotrRomanowski - Chairman of the Supervisory Board of the Company as aperson discharging managerial responsibilities in the Company, drawn upin relation to the sale of the Company's shares.
The notification is enclosed to this report.
More from RYVU Therapeutics S.A.
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
AGM Information
2026
May 29
AGM Information
2026
May 29
Regulatory Filings
2026
May 29
Governance Information
2026
May 29